PL3091005T3 - Pochodna 1,2-naftochinonu i sposób jej wytwarzania - Google Patents

Pochodna 1,2-naftochinonu i sposób jej wytwarzania

Info

Publication number
PL3091005T3
PL3091005T3 PL14877254T PL14877254T PL3091005T3 PL 3091005 T3 PL3091005 T3 PL 3091005T3 PL 14877254 T PL14877254 T PL 14877254T PL 14877254 T PL14877254 T PL 14877254T PL 3091005 T3 PL3091005 T3 PL 3091005T3
Authority
PL
Poland
Prior art keywords
preparing same
naphthoquinone derivative
naphthoquinone
derivative
preparing
Prior art date
Application number
PL14877254T
Other languages
English (en)
Inventor
Whee Seong Lee
Mi Jung Lee
Bo Jung KIM
Tae Cheul Roh
Seung Hoon Lee
Kyu Dae Lee
You-Hui Lee
Tae Hwan Kwak
Original Assignee
Huen Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huen Co., Ltd. filed Critical Huen Co., Ltd.
Publication of PL3091005T3 publication Critical patent/PL3091005T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/60—Naphthoxazoles; Hydrogenated naphthoxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL14877254T 2013-12-30 2014-12-30 Pochodna 1,2-naftochinonu i sposób jej wytwarzania PL3091005T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20130166912 2013-12-30
PCT/KR2014/013038 WO2015102369A1 (ko) 2013-12-30 2014-12-30 1,2 나프토퀴논 유도체 및 이의 제조방법
EP14877254.4A EP3091005B1 (en) 2013-12-30 2014-12-30 1,2-naphthoquinone derivative and method for preparing same

Publications (1)

Publication Number Publication Date
PL3091005T3 true PL3091005T3 (pl) 2021-04-19

Family

ID=53493651

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14877254T PL3091005T3 (pl) 2013-12-30 2014-12-30 Pochodna 1,2-naftochinonu i sposób jej wytwarzania

Country Status (10)

Country Link
US (1) US10927085B2 (pl)
EP (1) EP3091005B1 (pl)
JP (1) JP6903266B2 (pl)
KR (1) KR101739362B1 (pl)
CN (1) CN106103417B (pl)
AU (1) AU2014374601B2 (pl)
CA (1) CA2935319C (pl)
DK (1) DK3091005T3 (pl)
PL (1) PL3091005T3 (pl)
WO (1) WO2015102369A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105130936B (zh) * 2015-09-01 2017-09-26 中国药科大学 一类邻萘醌化合物、其制备方法和医药用途
US11684610B2 (en) 2018-04-09 2023-06-27 Yungjin Pharm. Co., Ltd. Pharmaceutical composition including 1,2-naphthoquinone derivative compound for prevention or treatment of solid cancers or blood cancers
US11717511B2 (en) 2018-04-09 2023-08-08 Huen Co., Ltd. Pharmaceutical composition comprising derivative compound of 1,2-naphthoquinone for preventing or treating solid cancer or blood cancer
KR102247694B1 (ko) * 2019-05-31 2021-05-03 주식회사 엘마이토테라퓨틱스 나프토퀴논 또는 벤조인다졸 화합물을 유효성분으로 포함하는 염증성 질환 치료용 약학적 조성물
CN111559991B (zh) * 2020-06-01 2022-01-25 河南省锐达医药科技有限公司 一种萘胺类化合物及其盐的制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080047957A (ko) * 2006-11-27 2008-05-30 주식회사 엠디바이오알파 고혈압의 치료 및 예방을 위한 약제 조성물
KR101468449B1 (ko) * 2007-04-26 2014-12-04 주식회사 케이티앤지생명과학 신규한 페난스렌퀴논계 화합물 및 이를 포함하는대사증후군 질환의 치료 또는 예방용 약제 조성물

Also Published As

Publication number Publication date
KR101739362B1 (ko) 2017-06-09
CA2935319C (en) 2022-07-19
AU2014374601A1 (en) 2016-06-30
EP3091005B1 (en) 2020-11-11
US20160376243A1 (en) 2016-12-29
DK3091005T3 (da) 2020-12-21
WO2015102369A1 (ko) 2015-07-09
CN106103417A (zh) 2016-11-09
JP6903266B2 (ja) 2021-07-14
CA2935319A1 (en) 2015-07-09
CN106103417B (zh) 2019-08-06
JP2017501204A (ja) 2017-01-12
EP3091005A1 (en) 2016-11-09
KR20150080425A (ko) 2015-07-09
US10927085B2 (en) 2021-02-23
AU2014374601B2 (en) 2019-05-23
EP3091005A4 (en) 2017-05-17

Similar Documents

Publication Publication Date Title
ZA201604328B (en) 1,2-naphthoquinone derivative and method for preparing same
EP3006415B8 (en) Method for producing nanocement and nanocement
SG10201407632UA (en) Transducer and method for forming the same
IL241046A0 (en) Fertilizer composition and method for its preparation
GB2528395B (en) Apparatus and methods for geosteering
EP3040331A4 (en) Tetrahydrocyclopentapyrrole derivative and preparation method therefor
IL245101B (en) Derivatives of 1,4-cyclohexylamine and processes for their preparation
SG10201710222YA (en) Retainer, method for producing same and use thereof
GB201406038D0 (en) Autotroph-based deodorizer and method for manufacturing the same
IL240665A0 (en) Improved aluminum-magnesium-lithium alloys and methods for their production
IL242437B (en) Compound 9, 5-dimethyl-9-hydroxy-decan-4-al, its use and its preparation process
EP3040754A4 (en) Imaging device, method, and program
EP3032307A4 (en) Imaging device, imaging method and program
ZA201601343B (en) Vancomycin derivative, and preparation method and application thereof
EP3001465A4 (en) Light-emitting element and method for preparing same
EP3064611A4 (en) Alloy-plate-coated material, and method for producing alloy-plate-coated material
PL3068728T3 (pl) Domieszkowany hydroksy-fosforan miedzi II, sposób jego wytwarzania i stosowania
SG11201507951SA (en) Method for producing 2,7-octadien-1-ol
EP3006952A4 (en) Positioning system, positioning method, and positioning program
GB201305947D0 (en) New method 1
ZA201602129B (en) Audiometry system and method
EP3018585A4 (en) Machine provision method, machine provision system, and machine provision program
EP3091005A4 (en) 1,2-naphthoquinone derivative and method for preparing same
EP2952519A4 (en) PROTOPANOXADIOL DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF
EP3041217A4 (en) Imaging device, method and program